Literature DB >> 24311612

Thrombospondin-1: the good, the bad, and the complicated.

Yonggang Ma1, Andriy Yabluchanskiy, Merry L Lindsey.   

Abstract

Entities:  

Keywords:  Editorial; diabetic cardiomyopathies; matrix metallopro teinase 9; proteomics; thrombospondin 1

Mesh：

Substances：

Year:  2013        PMID： 24311612      PMCID： PMC5846086          DOI： 10.1161/CIRCRESAHA.113.302749

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  23 in total

Review 1.  Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

Authors:  Patrick R Lawler; Jack Lawler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

Review 2.  Transforming growth factor-β/Smad signalling in diabetic nephropathy.

Authors:  Hui Yao Lan
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-08       Impact factor: 2.557

3.  Clinical and morphological features of human hypertensive-diabetic cardiomyopathy.

Authors:  S M Factor; T Minase; E H Sonnenblick
Journal:  Am Heart J       Date:  1980-04       Impact factor: 4.749

Review 4.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

5.  Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy?

Authors:  S M Factor; T Minase; S Cho; F Fein; J M Capasso; E H Sonnenblick
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

Review 6.  Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy.

Authors:  Damien Gerald; Sudhakar Chintharlapalli; Hellmut G Augustin; Laura E Benjamin
Journal:  Cancer Res       Date:  2013-03-06       Impact factor: 12.701

Review 7.  Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.

Authors:  Ashish Aneja; W H Wilson Tang; Sameer Bansilal; Mario J Garcia; Michael E Farkouh
Journal:  Am J Med       Date:  2008-09       Impact factor: 4.965

Review 8.  Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.

Authors:  Jeff S Isenberg; Gema Martin-Manso; Justin B Maxhimer; David D Roberts
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

Review 9.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

Review 10.  Diabetic cardiomyopathy: pathophysiology and clinical features.

Authors:  Takayuki Miki; Satoshi Yuda; Hidemichi Kouzu; Tetsuji Miura
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214
View more
  8 in total

Review 1.  Thrombospondins in the transition from myocardial infarction to heart failure.

Authors:  Jonathan A Kirk; Oscar H Cingolani
Journal:  J Mol Cell Cardiol       Date:  2015-12-10       Impact factor: 5.000

2.  Systematic analysis of lncRNA expression profiles and atherosclerosis-associated lncRNA-mRNA network revealing functional lncRNAs in carotid atherosclerotic rabbit models.

Authors:  Yingnan Wu; Feng Zhang; Xiaoying Li; Wenying Hou; Shuang Zhang; Yanan Feng; Rui Lu; Yu Ding; Litao Sun
Journal:  Funct Integr Genomics       Date:  2019-08-07       Impact factor: 3.410

3.  Suppression of Endothelial AGO1 Promotes Adipose Tissue Browning and Improves Metabolic Dysfunction.

Authors:  Xiaofang Tang; Yifei Miao; Yingjun Luo; Kiran Sriram; Zhijie Qi; Feng-Mao Lin; Yusu Gu; Chih-Hung Lai; Chien-Yi Hsu; Kirk L Peterson; Kendall Van Keuren-Jensen; Patrick T Fueger; Gene W Yeo; Rama Natarajan; Sheng Zhong; Zhen Bouman Chen
Journal:  Circulation       Date:  2020-05-12       Impact factor: 29.690

4.  β-adrenergic receptor-dependent alterations in murine cardiac transcript expression are differentially regulated by gefitinib in vivo.

Authors:  Jennifer A Talarico; Rhonda L Carter; Laurel A Grisanti; Justine E Yu; Ashley A Repas; Douglas G Tilley
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

5.  Hematopoietic Id Deletion Triggers Endomyocardial Fibrotic and Vascular Defects in the Adult Heart.

Authors:  Corey Chang; Qingshi Zhao; J Patrick Gonzalez; Jung H Kim; Kamal Alzahrani; Dominic Del Re; Diego Fraidenraich
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

6.  Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells.

Authors:  Rajshekhar A Kore; Jacob L Edmondson; Samir V Jenkins; Azemat Jamshidi-Parsian; Ruud P M Dings; Nathan S Reyna; Robert J Griffin
Journal:  Biochem Biophys Rep       Date:  2018-05-02

7.  Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines.

Authors:  Bernadette Jeremiasse; Csaba Matta; Christopher R Fellows; David J Boocock; Julia R Smith; Susan Liddell; Floris Lafeber; Willem E van Spil; Ali Mobasheri
Journal:  BMC Mol Cell Biol       Date:  2020-06-26

Review 8.  Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling.

Authors:  Yonggang Ma; Lisandra E de Castro Brás; Hiroe Toba; Rugmani Padmanabhan Iyer; Michael E Hall; Michael D Winniford; Richard A Lange; Suresh C Tyagi; Merry L Lindsey
Journal:  Pflugers Arch       Date:  2014-02-13       Impact factor: 3.657
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.